Ardelyx (ARDX) Total Liabilities (2013 - 2026)
Ardelyx (ARDX) posted Total Liabilities of $355.9 million for Q1 2026, up 6.34% on a QoQ basis from $334.7 million in Q4 2025, and up 34.54% year-over-year from $264.5 million in Q1 2025.
Ardelyx (ARDX) Total Liabilities (2013 - 2026) Analysis & Trends
Ardelyx's Total Liabilities history runs 14 years deep, the most recent figure standing at $355.9 million for Q1 2026.
- Quarterly Total Liabilities rose 34.54% year-over-year to $355.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $355.9 million (up 34.54% YoY) and the FY2025 annual result came in at $334.7 million, up 27.5% from the prior year.
- Total Liabilities was $355.9 million for Q1 2026 at Ardelyx, up from $334.7 million in the prior quarter.
- Across five years, Total Liabilities topped out at $355.9 million in Q1 2026 and bottomed at $65.2 million in Q1 2022.
- A 5-year average of $188.0 million and a median of $191.5 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities dropped 17.95% — and 2024, when it soared 123.19%.
- Ardelyx's Total Liabilities stood at $91.7 million in 2022, then surged by 42.54% to $130.8 million in 2023, then surged by 100.72% to $262.5 million in 2024, then climbed by 27.5% to $334.7 million in 2025, then gained by 6.34% to $355.9 million in 2026.
- Business Quant data shows ARDX's Total Liabilities at $355.9 million in Q1 2026, $334.7 million in Q4 2025, and $331.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 355.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355.89 Mn |
| Dec 31, 2025 | 334.66 Mn |
| Sep 30, 2025 | 331.89 Mn |
| Jun 30, 2025 | 327.24 Mn |
| Mar 31, 2025 | 264.52 Mn |
| Dec 31, 2024 | 262.47 Mn |
| Sep 30, 2024 | 209.57 Mn |
| Jun 30, 2024 | 196.50 Mn |
| Mar 31, 2024 | 191.49 Mn |
| Dec 31, 2023 | 130.76 Mn |
| Sep 30, 2023 | 98.22 Mn |
| Jun 30, 2023 | 88.04 Mn |
| Mar 31, 2023 | 91.60 Mn |
| Dec 31, 2022 | 91.74 Mn |
| Sep 30, 2022 | 77.81 Mn |
| Jun 30, 2022 | 78.57 Mn |
| Mar 31, 2022 | 65.22 Mn |
| Dec 31, 2021 | 67.30 Mn |
| Sep 30, 2021 | 89.42 Mn |
| Jun 30, 2021 | 87.41 Mn |